[go: up one dir, main page]

NO20030201L - Use of IL-8 receptor antagonists in the treatment of viral infections - Google Patents

Use of IL-8 receptor antagonists in the treatment of viral infections

Info

Publication number
NO20030201L
NO20030201L NO20030201A NO20030201A NO20030201L NO 20030201 L NO20030201 L NO 20030201L NO 20030201 A NO20030201 A NO 20030201A NO 20030201 A NO20030201 A NO 20030201A NO 20030201 L NO20030201 L NO 20030201L
Authority
NO
Norway
Prior art keywords
treatment
viral infections
receptor antagonists
exacerbation
directed
Prior art date
Application number
NO20030201A
Other languages
Norwegian (no)
Other versions
NO20030201D0 (en
Inventor
Susan B Dillon
Ruth Talsinger
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20030201D0 publication Critical patent/NO20030201D0/en
Publication of NO20030201L publication Critical patent/NO20030201L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Den foreliggende oppfinnelsen retter seg mot en ny anvendelse av en IL-8-reseptorantagonist for behandlingen av humane virusinfeksjoner og forverringer av symptomer assosiert med disse.The present invention is directed to a new use of an IL-8 receptor antagonist for the treatment of human viral infections and exacerbation of symptoms associated therewith.

NO20030201A 2000-07-18 2003-01-15 Use of IL-8 receptor antagonists in the treatment of viral infections NO20030201L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21905300P 2000-07-18 2000-07-18
PCT/US2001/022328 WO2002005814A1 (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections

Publications (2)

Publication Number Publication Date
NO20030201D0 NO20030201D0 (en) 2003-01-15
NO20030201L true NO20030201L (en) 2003-03-17

Family

ID=22817645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030201A NO20030201L (en) 2000-07-18 2003-01-15 Use of IL-8 receptor antagonists in the treatment of viral infections

Country Status (17)

Country Link
EP (1) EP1307190A4 (en)
JP (1) JP2004509852A (en)
KR (1) KR20030019587A (en)
CN (1) CN1449285A (en)
AR (1) AR033830A1 (en)
AU (1) AU2001273497A1 (en)
BR (1) BR0112603A (en)
CA (1) CA2418162A1 (en)
CZ (1) CZ2003132A3 (en)
HU (1) HUP0300754A3 (en)
IL (1) IL153921A0 (en)
MX (1) MXPA03000500A (en)
NO (1) NO20030201L (en)
NZ (1) NZ523659A (en)
PL (1) PL365886A1 (en)
WO (1) WO2002005814A1 (en)
ZA (1) ZA200300474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2575932A1 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
CR20160529A (en) * 2014-05-12 2017-01-02 Glaxosmithkline Intellectual Property (No 2) Ltd PHARMACEUTICAL COMPOSITIONS TO TREAT INFECTIOUS DISEASES
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP4125848A1 (en) * 2020-03-26 2023-02-08 Dompe' Farmaceutici SpA Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
AU3539795A (en) * 1994-08-25 1996-03-14 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 receptor antagonists
SE9802729D0 (en) * 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
SE9802937D0 (en) * 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
HUP0300754A3 (en) 2009-03-02
CZ2003132A3 (en) 2003-09-17
WO2002005814A1 (en) 2002-01-24
CN1449285A (en) 2003-10-15
JP2004509852A (en) 2004-04-02
KR20030019587A (en) 2003-03-06
BR0112603A (en) 2004-08-24
MXPA03000500A (en) 2003-06-24
AU2001273497A1 (en) 2002-01-30
PL365886A1 (en) 2005-01-10
ZA200300474B (en) 2004-08-17
EP1307190A4 (en) 2007-08-22
NO20030201D0 (en) 2003-01-15
HUP0300754A2 (en) 2003-08-28
CA2418162A1 (en) 2002-01-24
AR033830A1 (en) 2004-01-07
NZ523659A (en) 2006-01-27
IL153921A0 (en) 2003-07-31
EP1307190A1 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
HUP0400719A2 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
EA200300628A1 (en) CONNECTIONS SPECIFIC TO Adenosine A, A And Arecceptor, And Their Use
BR0110968A (en) Il-8 Receptor Antagonists
TR200000913T2 (en) Medical substances
MA30128B1 (en) PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND CIP INHIBITOR
FR16C1012I2 (en) THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
EA200100780A1 (en) TWEAK ANTAGONISTS AND TWEAK RECEPTORS AND THEIR USE FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES
PT951282E (en) PREVENTION AND TREATMENT OF SKELETAL DISEASES WITH SEL2TIVE PROTAGININES E2 AGONISTS OF EP2 RECEPTOR SUBTYPE
ATE425253T1 (en) TRIBONECTINS
ID29095A (en) MGLUR5 ANTAGONISTS FOR TREATMENT AND PAIN
DE60230722D1 (en) IL-8 RECEPTOR ANTAGONISTS
TR199900318T2 (en) IL-8 receptor antagonists.
IS2259B (en) Method for the treatment of retinopathy using antagonist of the integrin alfa-4 subunit
DZ3209A1 (en) Selective iGLuR5 receptor antagonists used in the treatment of migraine.
FR2815541B1 (en) USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY
PT1252150E (en) CONDENSED AZOIC DERIVATIVES AND THEIR USE AS HYPOGLYMATING AGENTS
ATE356994T1 (en) SCREENING METHOD WITH PIM1-KINASE OR PIM3-KINASE
EA200400399A1 (en) METHODS OF TREATMENT OF PULMONARY DISEASES
NO20030201L (en) Use of IL-8 receptor antagonists in the treatment of viral infections
DE60101559D1 (en) USE OF COMT INHIBITORS AS ANALGETICS
IS6426A (en) Piperazinomethylbenzamide as delta-opioid receptor agonist
EE200200517A (en) Monoclonal antibody, its preparation and use for detection and purification of the human low density lipoprotein receptor (LDLR)
UY28017A1 (en) THERAPEUTIC TREATMENT
TR200103448T2 (en) IL-8 receptor antagonists.
DK1421377T3 (en) Natural ligand for the orphan G protein-coupled receptor GPR86 and methods of use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application